comparemela.com

Latest Breaking News On - Company data on file - Page 1 : comparemela.com

atHeart Medical Receives FDA Approval for the Second Phase of the ASCENT ASD U.S. IDE Trial

/PRNewswire/ atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today.

United-states
France
Switzerland
Sept-occluder
Laurent-grandidier
Katie-arnold
University-of-virginia
Company-data-on-file
Scott-lim
Device-exemption
Trial-identifier
Heart-medical

atHeart Medical Receives FDA Approval for the Second Phase of the ASCENT ASD U.S. IDE Trial

/PRNewswire/ atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today.

United-states
France
Switzerland
Sept-occluder
Laurent-grandidier
Katie-arnold
University-of-virginia
Company-data-on-file
Heart-medical
Device-exemption
Scott-lim
Trial-identifier

atHeart Medical Receives FDA Approval for the Second Phase of the ASCENT ASD U.S. IDE Trial

/PRNewswire/ atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today.

United-states
France
Switzerland
Sept-occluder
Laurent-grandidier
Katie-arnold
University-of-virginia
Company-data-on-file
Heart-medical
Device-exemption
Scott-lim
Trial-identifier

First Five Patients Successfully Treated with atHeart Medical's Novel reSept Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial

First Five Patients Successfully Treated with atHeart Medical's Novel reSept Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states
California
Thousand-oaks
Switzerland
Thomas-forbes
Thomas-jones
Kostenloser-wertpapierhandel
Laurent-grandidier
Saibal-kar
Katie-arnold
Valve-center
Catheterization-laboratory

First Five Patients Successfully Treated with atHeart Medical's Novel reSept™ Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial

First Five Patients Successfully Treated with atHeart Medical's Novel reSept™ Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United-states
California
Thousand-oaks
Switzerland
Laurent-grandidier
Saibal-kar
Katie-arnold
Los-robles-regional-medical-center
Company-data-on-file
Interventional-cardiology
Co-principal-investigator
Device-exemption
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.